Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$533M |
| 2 |
Apple
AAPL
|
+$347M |
| 3 |
Micron Technology
MU
|
+$272M |
| 4 |
Eli Lilly
LLY
|
+$232M |
| 5 |
Super Micro Computer
SMCI
|
+$185M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$472M |
| 2 |
NVIDIA
NVDA
|
+$413M |
| 3 |
Tesla
TSLA
|
+$403M |
| 4 |
Coinbase
COIN
|
+$236M |
| 5 |
Johnson & Johnson
JNJ
|
+$224M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.66% |
| 2 | Healthcare | 16.81% |
| 3 | Consumer Discretionary | 13.04% |
| 4 | Industrials | 9.63% |
| 5 | Financials | 9.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SOGP
3376
Sound Group
SOGP
$51.2M
| $37.7K | ﹤0.01% |
15,158
| – | – |
|
|
JBIO
3377
Jade Biosciences
JBIO
$1.17B
| $37.4K | ﹤0.01% |
+511
| New | +$33K |
|
3378
Newegg Commerce
NEGG
$283M
| $37.3K | ﹤0.01% |
+2,526
| New | +$43.2K |
|
3379
Outset Medical
OM
$92.5M
| $36.7K | ﹤0.01% |
+3,612
| New | +$107K |
|
3380
Quantum-Si Incorporated
QSI
$162M
| $36.7K | ﹤0.01% |
+41,556
| New | +$40.3K |
|
|
PTN
3381
Palatin Technologies
PTN
$14.6M
| $36.5K | ﹤0.01% |
+817
| New | +$62K |
|
|
AMTD
3382
AMTD IDEA Group
AMTD
$67.4M
| $36.2K | ﹤0.01% |
25,666
+13,000
| +103% | +$18.3K |
|
3383
Banco Bradesco
BBDO
$35.7B
| $35.3K | ﹤0.01% |
14,400
-10,400
| -42% | -$24.1K |
|
3384
BioRestorative Therapies
BRTX
$5.04M
| $34.8K | ﹤0.01% |
+20,000
| New | +$32.9K |
|
3385
SU Group Holdings
SUGP
$1.72M
| $33.8K | ﹤0.01% |
+2,506
| New | +$52.9K |
|
3386
Alpha Tau Medical
DRTS
$1.08B
| $33.8K | ﹤0.01% |
+14,200
| New | +$31.4K |
|
3387
Anixa Biosciences
ANIX
$116M
| $33.6K | ﹤0.01% |
+10,673
| New | +$32.8K |
|
3388
Indaptus Therapeutics
INDP
$175M
| $33.6K | ﹤0.01% |
968
+18
| +2% | +$884 |
|
|
BRNS
3389
Barinthus Biotherapeutics
BRNS
$24.5M
| $33.2K | ﹤0.01% |
27,900
+2,800
| +11% | +$3.76K |
|
3390
Dolphin Entertainment
DLPN
$13.8M
| $33K | ﹤0.01% |
26,200
+1,050
| +4% | +$1.59K |
|
|
RTB
3391
RTB Digital
RTB
$211M
| $32.6K | ﹤0.01% |
705
-479
| -40% | -$24.7K |
|
|
TKLF
3392
Yoshitsu Co
TKLF
$8.93M
| $31.6K | ﹤0.01% |
+5,400
| New | +$29.7K |
|
3393
MDxHealth
MDXH
$23.4M
| $31.4K | ﹤0.01% |
+15,100
| New | +$41K |
|
|
ENFY
3394
DELISTED
Enlightify Inc
ENFY
| $31.4K | ﹤0.01% |
12,451
-300
| -2% | -$577 |
|
3395
Moleculin Biotech
MBRX
$3M
| $31.2K | ﹤0.01% |
+440
| New | +$31.7K |
|
3396
Unusual Machines
UMAC
$1.1B
| $30.7K | ﹤0.01% |
+20,173
| New | +$33.3K |
|
3397
Haoxi Health Technology Ltd
HAO
$1.2M
| $30.1K | ﹤0.01% |
+26
| New | +$306K |
|
3398
iPower
IPW
$1.06M
| $30K | ﹤0.01% |
69
-102
| -60% | -$37.6K |
|
3399
DSS Inc
DSS
$5.35M
| $29.5K | ﹤0.01% |
23,248
+1,100
| +5% | +$1.57K |
|
3400
Socket Mobile
SCKT
$3.39M
| $29.3K | ﹤0.01% |
25,500
+1,400
| +6% | +$1.54K |
|
Similar funds
Renaissance Technologies's Q3 2024 Portfolio in Review
As of Q3 2024, Renaissance Technologies held 4,024 positions worth $66.5B, up 13% from $59B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Renaissance Technologies deployed $3.2B of net new capital in Q3 2024, opening 578 new positions and adding to 1,558 existing holdings. Its largest new stake was Micron Technology: 2,604,914 shares worth $270M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was NVIDIA, an estimated $413M trimmed.
- Renaissance Technologies's largest Q3 2024 buy was Micron Technology: 2,604,914 shares worth $270M.
- Renaissance Technologies added most to Microsoft in Q3 2024, an estimated $533M increase.
- Renaissance Technologies's biggest Q3 2024 reduction was NVIDIA, cutting an estimated $413M.
- Renaissance Technologies fully exited Broadcom in Q3 2024, selling an estimated $472M.
- Renaissance Technologies's ten largest holdings make up 11% of its $66.5B portfolio in Q3 2024.
- Renaissance Technologies opened 578 new positions and closed 539 in Q3 2024.
- Renaissance Technologies's portfolio value rose 13% quarter-over-quarter to $66.5B.
Based on Renaissance Technologies's 13F filing for Q3 2024, filed 13 Nov 2024.